Silicon Laboratories Inc.
SLAB
$128.77
-$3.00-2.28%
NASDAQ
| 04/05/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.06% | 91.43% | -18.34% | -40.63% | -56.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.06% | 91.43% | -18.34% | -40.63% | -56.90% |
| Cost of Revenue | 55.80% | 77.14% | -10.21% | -31.96% | -44.79% |
| Gross Profit | 77.55% | 105.40% | -24.12% | -46.73% | -64.21% |
| SG&A Expenses | 24.10% | 8.26% | 32.51% | -4.94% | -25.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.76% | 21.83% | 2.38% | -15.07% | -27.16% |
| Operating Income | 45.75% | 60.84% | -343.17% | -379.73% | -402.12% |
| Income Before Tax | 49.80% | 69.63% | -292.92% | -295.30% | -362.02% |
| Income Tax Expenses | 593.25% | 86.57% | -40.82% | 197.16% | -104.97% |
| Earnings from Continuing Operations | 46.10% | 65.86% | -375.45% | -849.88% | -504.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.10% | 65.86% | -375.45% | -849.88% | -504.71% |
| EBIT | 45.75% | 60.84% | -343.17% | -379.73% | -402.12% |
| EBITDA | 56.07% | 71.85% | -172.41% | -219.00% | -243.64% |
| EPS Basic | 47.02% | 66.47% | -371.11% | -837.88% | -505.35% |
| Normalized Basic EPS | 50.66% | 70.17% | -289.85% | -292.20% | -362.41% |
| EPS Diluted | 46.93% | 66.52% | -375.69% | -875.76% | -532.05% |
| Normalized Diluted EPS | 50.66% | 70.17% | -291.55% | -300.16% | -377.15% |
| Average Basic Shares Outstanding | 1.74% | 1.80% | 1.61% | 1.61% | -0.15% |
| Average Diluted Shares Outstanding | 1.74% | 1.80% | 0.72% | -2.44% | -5.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |